• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[塞利洛尔可增加原发性高血压患者皮下组织和小腿肌肉的微循环]

[Celiprolol increases the microcirculation in subcutaneous tissue and calf muscles in essential hypertension].

作者信息

Pechán J, Cesnaková Z, Balazovjech I

机构信息

I. interná klinika LFUK a FN v Bratislave, Slovakia.

出版信息

Bratisl Lek Listy. 1993 Jan;94(1):33-6.

PMID:8353737
Abstract

The microcirculation of the subcutaneous tissue and muscles of the extremities is changed already in the early stage of essential hypertension. Insight into the effect of celiprolol, a beta blocker of the third generation, on tissue microcirculation is of both pathogenetic and therapeutic value. On using the method of Na131I tissue clearance, the effect of celiprolol on the microcirculation of subcutaneous tissue and muscles of the extremities was studied in 21 patients with essential hypertension. Celiprolol was administered orally in the daily dose of 300 mg. After one-week administration celiprolol significantly reduced mean arterial pressure and significantly increased the microcirculation in the subcutaneous tissue of the hand and crus as well as in the calf muscle. Celiprolol was thus found to increase the microcirculation in those tissues of the extremities in which its decrease was recorded before onset of the treatment. The obtained results may be of therapeutic value particularly in patients suffering from ischemia of the lower extremities. (Fig. 2, Ref. 19.).

摘要

在原发性高血压的早期阶段,四肢皮下组织和肌肉的微循环就已发生改变。了解第三代β受体阻滞剂塞利洛尔对组织微循环的影响具有病因学和治疗学价值。采用¹³¹碘钠组织清除法,对21例原发性高血压患者研究了塞利洛尔对四肢皮下组织和肌肉微循环的影响。塞利洛尔口服给药,日剂量为300毫克。给药一周后,塞利洛尔显著降低平均动脉压,并显著增加手部和小腿皮下组织以及小腿肌肉的微循环。因此发现,塞利洛尔可增加四肢那些在治疗前记录到微循环减少的组织的微循环。所得结果可能具有治疗价值,尤其对于患有下肢缺血的患者。(图2,参考文献19。)

相似文献

1
[Celiprolol increases the microcirculation in subcutaneous tissue and calf muscles in essential hypertension].[塞利洛尔可增加原发性高血压患者皮下组织和小腿肌肉的微循环]
Bratisl Lek Listy. 1993 Jan;94(1):33-6.
2
[Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].[心脏选择性和非心脏选择性β受体阻滞剂对动脉闭塞性疾病患者外周循环影响的比较研究]
Wien Klin Wochenschr. 1986 Feb 7;98(3):70-3.
3
A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.血管扩张β1 受体阻滞剂塞利洛尔可抑制原发性高血压患者肌肉释放尿酸前体。
Horm Metab Res. 2013 Jan;45(1):69-73. doi: 10.1055/s-0032-1321872. Epub 2012 Aug 14.
4
[Microcirculation in the subcutaneous layer and in muscles in diabetes mellitus].[糖尿病患者皮下组织和肌肉中的微循环]
Vnitr Lek. 1990 Nov;36(11):1113-8.
5
Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.塞利普罗和阿替洛尔对轻至中度高血压患者的不同血流动力学效应。
Arzneimittelforschung. 1995 Jul;45(7):790-5.
6
[Regional microcirculation of the skin and muscles in healthy and paretic extremities before and after the development of cerebral infarct].
Cesk Neurol Neurochir. 1982 Jul;45(4):212-8.
7
[Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].[β受体阻滞剂或血管紧张素转换酶抑制剂治疗慢性肾小球肾炎时的肾脏血流动力学与蛋白尿]
Dtsch Med Wochenschr. 1997 Aug 1;122(31-32):953-8. doi: 10.1055/s-2008-1047714.
8
Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: contrasting results after administration of celiprolol and metoprolol.β-肾上腺素能拮抗剂对左心室舒张功能的急性影响:服用塞利洛尔和美托洛尔后的对比结果。
J Hum Hypertens. 1994 Feb;8(2):127-32.
9
Capillary blood flow in subcutaneous tissue and muscle in essential hypertension.原发性高血压患者皮下组织和肌肉中的毛细血管血流
Cardiology. 1974;59(2):123-32. doi: 10.1159/000169671.
10
Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives.添加β-2激动剂并不能改善高血压患者β-1阻滞剂的运动反应。
Med Sci Sports Exerc. 1994 Aug;26(8):945-50.